ImmuCell Corporation Increase (Decrease) in Accounts and Other Receivables
ImmuCell Corporation (ICCC) reported Increase (Decrease) in Accounts and Other Receivables of $105.98 thousand for the 9-month period ending 2023-09-30, per its 10-Q filed 2023-11-13.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsAndOtherReceivables · last filed 2023-11-13
- ImmuCell Corporation increase (decrease) in accounts and other receivables for the quarter ending 2023-09-30 was $365.74K, a 26.94% increase year-over-year.
- ImmuCell Corporation increase (decrease) in accounts and other receivables for the quarter ending 2023-06-30 was -$591.45K.
- ImmuCell Corporation increase (decrease) in accounts and other receivables for the quarter ending 2023-03-31 was $331.70K.
- ImmuCell Corporation increase (decrease) in accounts and other receivables for the quarter ending 2022-12-31 was $56.77K, a 79.13% decline year-over-year.
- ImmuCell Corporation increase (decrease) in accounts and other receivables for fiscal 2022 was -$935.63K, a 204.26% decline from fiscal 2021.
- ImmuCell Corporation increase (decrease) in accounts and other receivables for fiscal 2021 was $897.43K, a 462.17% increase from fiscal 2020.
- ImmuCell Corporation increase (decrease) in accounts and other receivables for fiscal 2020 was $159.64K, a 77.35% decline from fiscal 2019.
- ImmuCell Corporation increase (decrease) in accounts and other receivables for fiscal 2019 was $704.87K.
| Period end | Increase (Decrease) in Accounts and Other Receivables 3 month | Increase (Decrease) in Accounts and Other Receivables 6 month | Increase (Decrease) in Accounts and Other Receivables 9 month | Increase (Decrease) in Accounts and Other Receivables 12 month |
|---|---|---|---|---|
| 2023-09-30 | $365.74K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13 | -$225.71K derived: sum of 2 quarters · filed 2023-11-13 | $105.98K 10-Q · filed 2023-11-13 | $162.75K derived: sum of 4 quarters · filed 2023-11-13 |
| 2023-06-30 | -$591.45K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-10 | -$259.75K 10-Q · filed 2023-08-10 | -$202.98K derived: sum of 3 quarters · filed 2023-08-10 | $85.14K derived: sum of 4 quarters · filed 2023-11-13 |
| 2023-03-31 | $331.70K 10-Q · filed 2023-05-11 | $388.47K derived: sum of 2 quarters · filed 2023-05-11 | $676.60K derived: sum of 3 quarters · filed 2023-11-13 | -$562.29K derived: sum of 4 quarters · filed 2023-11-13 |
| 2022-12-31 | $56.77K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-29 | $344.90K derived: sum of 2 quarters · filed 2023-11-13 | -$893.99K derived: sum of 3 quarters · filed 2023-11-13 | -$935.63K 10-K · filed 2023-03-29 |
| 2022-09-30 | $288.13K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13 | -$950.76K derived: sum of 2 quarters · filed 2023-11-13 | -$992.40K 10-Q · filed 2023-11-13 | -$720.42K derived: sum of 4 quarters · filed 2023-11-13 |
| 2022-06-30 | -$1.24M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-10 | -$1.28M 10-Q · filed 2023-08-10 | -$1.01M derived: sum of 3 quarters · filed 2023-08-10 | -$636.24K derived: sum of 4 quarters · filed 2023-08-10 |
| 2022-03-31 | -$41.64K 10-Q · filed 2023-05-11 | $230.34K derived: sum of 2 quarters · filed 2023-05-11 | $602.64K derived: sum of 3 quarters · filed 2023-05-11 | $262.39K derived: sum of 4 quarters · filed 2023-05-11 |
| 2021-12-31 | $271.97K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-29 | $644.28K derived: sum of 2 quarters · filed 2023-03-29 | $304.02K derived: sum of 3 quarters · filed 2023-03-29 | $897.43K 10-K · filed 2023-03-29 |
| 2021-09-30 | $372.31K derived: 10-Q 9 month − 10-Q/A 6 month · filed 2022-11-21 | $32.05K derived: sum of 2 quarters · filed 2022-11-21 | $625.45K 10-Q · filed 2022-11-21 | $879.71K derived: sum of 4 quarters · filed 2022-11-21 |
| 2021-06-30 | -$340.26K derived: 10-Q/A 6 month − 10-Q/A 3 month · filed 2022-11-21 | $253.15K 10-Q/A · filed 2022-11-21 | $507.40K derived: sum of 3 quarters · filed 2022-11-21 | $1.07M derived: sum of 4 quarters · filed 2022-11-21 |
| 2021-03-31 | $593.40K 10-Q/A · filed 2022-11-21 | $847.66K derived: sum of 2 quarters · filed 2022-11-21 | $1.41M derived: sum of 3 quarters · filed 2022-11-21 | $514.42K derived: sum of 4 quarters · filed 2022-11-21 |
| 2020-12-31 | $254.26K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-30 | $813.95K derived: sum of 2 quarters · filed 2022-03-30 | -$78.98K derived: sum of 3 quarters · filed 2022-03-30 | $159.64K 10-K · filed 2022-03-30 |
| 2020-09-30 | $559.70K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-15 | -$333.24K derived: sum of 2 quarters · filed 2021-11-15 | -$94.62K 10-Q · filed 2021-11-15 | $655.84K derived: sum of 4 quarters · filed 2021-11-15 |
| 2020-06-30 | -$892.94K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-12 | -$654.32K 10-Q · filed 2021-08-12 | $96.14K derived: sum of 3 quarters · filed 2021-08-12 | $51.35K derived: sum of 4 quarters · filed 2021-08-12 |
| 2020-03-31 | $238.62K 10-Q · filed 2021-05-13 | $989.08K derived: sum of 2 quarters · filed 2021-05-13 | $944.29K derived: sum of 3 quarters · filed 2021-05-13 | $592.69K derived: sum of 4 quarters · filed 2021-05-13 |
| 2019-12-31 | $750.46K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-30 | $705.67K derived: sum of 2 quarters · filed 2021-03-30 | $354.07K derived: sum of 3 quarters · filed 2021-03-30 | $704.87K 10-K · filed 2021-03-30 |
| 2019-09-30 | -$44.79K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-12 | -$396.39K derived: sum of 2 quarters · filed 2020-11-12 | -$45.59K 10-Q · filed 2020-11-12 | $32.73K derived: sum of 4 quarters · filed 2020-11-12 |
| 2019-06-30 | -$351.60K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-12 | -$805.00 10-Q · filed 2020-08-12 | $77.52K derived: sum of 3 quarters · filed 2020-08-12 | -$53.72K derived: sum of 4 quarters · filed 2020-08-12 |
| 2019-03-31 | $350.80K 10-Q · filed 2020-05-13 | $429.12K derived: sum of 2 quarters · filed 2020-05-13 | $297.88K derived: sum of 3 quarters · filed 2020-05-13 | |
| 2018-12-31 | $78.33K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-27 | -$52.92K derived: sum of 2 quarters · filed 2020-03-27 | -$411.72K 10-K · filed 2020-03-27 | |
| 2018-09-30 | -$131.24K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12 | -$490.05K 10-Q · filed 2019-11-12 | ||
| 2018-06-30 | -$358.81K 10-Q · filed 2019-08-12 | |||
| 2017-12-31 | $471.42K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-22 | $330.31K 10-K · filed 2019-03-22 | ||
| 2017-09-30 | -$141.11K 10-Q · filed 2018-11-13 | |||
| 2016-03-31 | -$3.64K 10-Q · filed 2016-05-11 | $9.74K derived: sum of 2 quarters · filed 2016-05-11 | $14.12K derived: sum of 3 quarters · filed 2016-05-11 | $16.09K derived: sum of 4 quarters · filed 2016-05-11 |
| 2015-12-31 | $13.38K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-25 | $17.76K derived: sum of 2 quarters · filed 2016-03-25 | $19.73K derived: sum of 3 quarters · filed 2016-03-25 | $19.50K 10-K · filed 2016-03-25 |
| 2015-09-30 | $4.38K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-12 | $6.36K derived: sum of 2 quarters · filed 2015-11-12 | $6.13K 10-Q · filed 2015-11-12 | -$4.74K derived: sum of 4 quarters · filed 2015-11-12 |
| 2015-06-30 | $1.97K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-13 | $1.75K 10-Q · filed 2015-08-13 | -$9.13K derived: sum of 3 quarters · filed 2015-08-13 | -$5.26K derived: sum of 4 quarters · filed 2015-08-13 |
| 2015-03-31 | -$226.00 10-Q · filed 2015-05-12 | -$11.10K derived: sum of 2 quarters · filed 2015-05-12 | -$7.23K derived: sum of 3 quarters · filed 2015-05-12 | -$2.54K derived: sum of 4 quarters · filed 2015-05-12 |
| 2014-12-31 | -$10.87K derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-26 | -$7.00K derived: sum of 2 quarters · filed 2015-03-26 | -$2.31K derived: sum of 3 quarters · filed 2015-03-26 | -$19.18K 10-K · filed 2015-03-26 |
| 2014-09-30 | $3.87K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-12 | $8.56K derived: sum of 2 quarters · filed 2014-11-12 | -$8.31K 10-Q · filed 2014-11-12 | |
| 2014-06-30 | $4.69K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-13 | -$12.18K 10-Q · filed 2014-08-13 | ||
| 2014-03-31 | -$16.87K 10-Q · filed 2014-05-14 | |||
| 2013-12-31 | -$1.18K 10-K · filed 2014-03-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |